Activ Surgical has sought FDA clearance for ActivSight and is anticipated to become commercially available this year. Credit: Mike Bartoszek.

Digital surgery innovator Activ Surgical has announced that it has been named the newest member of Microsoft for Startups, a programme that helps B2B start-ups with successful scaling.

With the development, Activ Surgical will have exclusive access to Microsoft’s technologies such as Azure and an efficient path to selling alongside Microsoft and its global partner ecosystem.

Furthermore, Activ Surgical’s participation in the programme and collaboration with Microsoft will aid in increasing opportunities for hospitals and healthcare systems in the US and international markets to use its recently announced ActivEdge platform.

An artificial intelligence (AI) and machine learning (ML) hardware-agnostic platform, ActivEdge enables existing surgical systems to see in real-time what humans are not able to see, including blood flow.

The first product to be launched from ActivEdge, the company’s ActivSight offers real-time views of blood perfusion without requiring dye injection and enables fluorescing of indocyanine green (ICG) dye.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, it operates dynamically and effortlessly with any installed visualisation system to deliver real-time intraoperative visual data and images not available at present to surgeons using existing technologies.

Activ Surgical chief technology officer Tom Calef said: “Our participation in the programme comes at a critical time in our company’s history as we prepare for the commercialisation of our first product, ActivSight, later this year.

“And, given our ActivEdge platform is currently powered by Microsoft Azure, we will now have expanded access to resources, capabilities, and ecosystem partners that will ensure the success of the go-to-market rollout.”

The company noted that it has sought the Food and Drug Administration (FDA) clearance for ActivSight and is anticipated to be commercially available this year.

Microsoft for Startups Health & Life Sciences WW Lead Sally Frank said: “Activ Surgical’s mission to save lives and improve patient safety and outcomes by reducing surgical errors in the operating room is bold and represents the types of companies we want to align with as part of our start-up programme.”